Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 1/2017

Ausgabe 1/2017

Inhaltsverzeichnis ( 18 Artikel )

25.10.2016 | Review | Ausgabe 1/2017

Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel–cyclophosphamide chemotherapy for breast cancer: a systematic review

Ricardo Fernandes, Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Shaan Dudani, Mohamed F. K. Ibrahim, Habeeb Majeed, Kirstin Perdrizet, Risa Shorr, Brian Hutton, Dean Fergusson, Mark Clemons

25.10.2016 | Review | Ausgabe 1/2017

Can we prevent BRCA1-associated breast cancer by RANKL inhibition?

Joanne Kotsopoulos, Christian Singer, Steven A. Narod

26.10.2016 | Preclinical study | Ausgabe 1/2017

Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast

Michael J. Campbell, Frederick Baehner, Tess O’Meara, Ekene Ojukwu, Booyeon Han, Rita Mukhtar, Vickram Tandon, Max Endicott, Zelos Zhu, Jasmine Wong, Gregor Krings, Alfred Au, Joe W. Gray, Laura Esserman

27.10.2016 | Preclinical study | Ausgabe 1/2017

Up-regulation of cathepsin S expression by HSP90 and 5-HT7 receptor-dependent serotonin signaling correlates with triple negativity of human breast cancer

Jaya Gautam, Young Kyung Bae, Jung-Ae Kim

04.11.2016 | Preclinical study | Ausgabe 1/2017

Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer

Dominic Amara, Denise M. Wolf, Laura van ’t Veer, Laura Esserman, Michael Campbell, Christina Yau

27.10.2016 | Clinical trial | Ausgabe 1/2017

Peripheral T cell responses to tumour antigens are associated with molecular, immunogenetic and cellular features of breast cancer patients

Nicole Janssen, Sotirios P. Fortis, Lisa Speigl, Christoforos Haritos, Nectaria N. Sotiriadou, Michael Sofopoulos, Niki Arnogiannaki, Catherine Stavropoulos-Giokas, Amalia Dinou, Sonia Perez, Graham Pawelec, Constantin N. Baxevanis, Christopher Shipp

31.10.2016 | Clinical trial | Ausgabe 1/2017 Open Access

A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study

Nadia Harbeck, Steffen Saupe, Elke Jäger, Marcus Schmidt, Rolf Kreienberg, Lothar Müller, Burkhard Joerg Otremba, Dirk Waldenmaier, Julia Dorn, Mathias Warm, Michael Scholz, Michael Untch, Maike de Wit, Jana Barinoff, Hans-Joachim Lück, Philipp Harter, Doris Augustin, Paul Harnett, Matthias W. Beckmann, Salah-Eddin Al-Batran, On behalf of the PELICAN Investigators

02.11.2016 | Clinical trial | Ausgabe 1/2017

Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis

Clémentine Jankowski, S. Guiu, M. Cortet, C. Charon-Barra, I. Desmoulins, V. Lorgis, L. Arnould, P. Fumoleau, B. Coudert, R. Rouzier, C. Coutant, F. Reyal

22.10.2016 | Epidemiology | Ausgabe 1/2017

Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer

Chun Wang, Zhaomei Mu, Inna Chervoneva, Laura Austin, Zhong Ye, Giovanna Rossi, Juan P. Palazzo, Carl Sun, Maysa Abu-Khalaf, Ronald E. Myers, Zhu Zhu, Yanna Ba, Bingshan Li, Lifang Hou, Massimo Cristofanilli, Hushan Yang

25.10.2016 | Epidemiology | Ausgabe 1/2017

Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer

Haeyoung Kim, Dae-Yeon Cho, Doo Ho Choi, Mijin Oh, Inkyung Shin, Won Park, Seung Jae Huh, Seok Jin Nam, Jeong Eon Lee, Seok Won Kim

28.10.2016 | Epidemiology | Ausgabe 1/2017

The impact of nodal micrometastasis on mortality among women with early-stage breast cancer

Javaid Iqbal, Ophira Ginsburg, Vasily Giannakeas, Paula A. Rochon, John L. Semple, Steven A. Narod

28.10.2016 | Epidemiology | Ausgabe 1/2017 Open Access

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

Yosr Hamdi, Penny Soucy, Karoline B. Kuchenbaeker, Tomi Pastinen, Arnaud Droit, Audrey Lemaçon, Julian Adlard, Kristiina Aittomäki, Irene L. Andrulis, Adalgeir Arason, Norbert Arnold, Banu K. Arun, Jacopo Azzollini, Anita Bane, Laure Barjhoux, Daniel Barrowdale, Javier Benitez, Pascaline Berthet, Marinus J. Blok, Kristie Bobolis, Valérie Bonadona, Bernardo Bonanni, Angela R. Bradbury, Carole Brewer, Bruno Buecher, Saundra S. Buys, Maria A. Caligo, Jocelyne Chiquette, Wendy K. Chung, Kathleen B. M. Claes, Mary B. Daly, Francesca Damiola, Rosemarie Davidson, Miguel De la Hoya, Kim De Leeneer, Orland Diez, Yuan Chun Ding, Riccardo Dolcetti, Susan M. Domchek, Cecilia M. Dorfling, Diana Eccles, Ros Eeles, Zakaria Einbeigi, Bent Ejlertsen, Christoph Engel, D. Gareth Evans, Lidia Feliubadalo, Lenka Foretova, Florentia Fostira, William D. Foulkes, George Fountzilas, Eitan Friedman, Debra Frost, Pamela Ganschow, Patricia A. Ganz, Judy Garber, Simon A. Gayther, Anne-Marie Gerdes, Gord Glendon, Andrew K. Godwin, David E. Goldgar, Mark H. Greene, Jacek Gronwald, Eric Hahnen, Ute Hamann, Thomas V. O. Hansen, Steven Hart, John L. Hays, Frans B. L. Hogervorst, Peter J. Hulick, Evgeny N. Imyanitov, Claudine Isaacs, Louise Izatt, Anna Jakubowska, Paul James, Ramunas Janavicius, Uffe Birk Jensen, Esther M. John, Vijai Joseph, Walter Just, Katarzyna Kaczmarek, Beth Y. Karlan, Carolien M. Kets, Judy Kirk, Mieke Kriege, Yael Laitman, Maïté Laurent, Conxi Lazaro, Goska Leslie, Jenny Lester, Fabienne Lesueur, Annelie Liljegren, Niklas Loman, Jennifer T. Loud, Siranoush Manoukian, Milena Mariani, Sylvie Mazoyer, Lesley McGuffog, Hanne E. J. Meijers-Heijboer, Alfons Meindl, Austin Miller, Marco Montagna, Anna Marie Mulligan, Katherine L. Nathanson, Susan L. Neuhausen, Heli Nevanlinna, Robert L. Nussbaum, Edith Olah, Olufunmilayo I. Olopade, Kai-ren Ong, Jan C. Oosterwijk, Ana Osorio, Laura Papi, Sue Kyung Park, Inge Sokilde Pedersen, Bernard Peissel, Pedro Perez Segura, Paolo Peterlongo, Catherine M. Phelan, Paolo Radice, Johanna Rantala, Christine Rappaport-Fuerhauser, Gad Rennert, Andrea Richardson, Mark Robson, Gustavo C. Rodriguez, Matti A. Rookus, Rita Katharina Schmutzler, Nicolas Sevenet, Payal D. Shah, Christian F. Singer, Thomas P. Slavin, Katie Snape, Johanna Sokolowska, Ida Marie Heeholm Sønderstrup, Melissa Southey, Amanda B. Spurdle, Zsofia Stadler, Dominique Stoppa-Lyonnet, Grzegorz Sukiennicki, Christian Sutter, Yen Tan, Muy-Kheng Tea, Manuel R. Teixeira, Alex Teulé, Soo-Hwang Teo, Mary Beth Terry, Mads Thomassen, Laima Tihomirova, Marc Tischkowitz, Silvia Tognazzo, Amanda Ewart Toland, Nadine Tung, Ans M. W. van den Ouweland, Rob B. van der Luijt, Klaartje van Engelen, Elizabeth J. van Rensburg, Raymonda Varon-Mateeva, Barbara Wappenschmidt, Juul T. Wijnen, Timothy Rebbeck, Georgia Chenevix-Trench, Kenneth Offit, Fergus J. Couch, Silje Nord, Douglas F. Easton, Antonis C. Antoniou, Jacques Simard, EMBRACE, GEMO Study Collaborators, HEBON, KConFab Investigators

31.10.2016 | Epidemiology | Ausgabe 1/2017

Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel

Olivia Moran, Dina Nikitina, Robert Royer, Aletta Poll, Kelly Metcalfe, Steven A. Narod, Mohammad R. Akbari, Joanne Kotsopoulos

01.11.2016 | Epidemiology | Ausgabe 1/2017

3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study)

Hiltrud Merzenich, Detlef Bartkowiak, Heinz Schmidberger, Marcus Schmidt, Lukas Schwentner, Thomas Wiegel, Achim Woeckel, Daniel Wollschläger, Maria Blettner

04.11.2016 | Epidemiology | Ausgabe 1/2017

A model for individualized risk prediction of contralateral breast cancer

Marzana Chowdhury, David Euhus, Tracy Onega, Swati Biswas, Pankaj K. Choudhary

08.11.2016 | Epidemiology | Ausgabe 1/2017

Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors

Gregory S. Calip, Joann G. Elmore, Denise M. Boudreau

03.11.2016 | Brief Report | Ausgabe 1/2017

Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy

Lior Z. Braunstein, Alphonse G. Taghian, Andrzej Niemierko, Laura Salama, Alexander Capuco, Jennifer R. Bellon, Julia S. Wong, Rinaa S. Punglia, Shannon M. MacDonald, Jay R. Harris

24.10.2016 | Letter to the Editor | Ausgabe 1/2017

A prospective study of peripheral blood DNA methylation at RPTOR, MGRN1 and RAPSN and risk of breast cancer

Pierre-Antoine Dugué, Roger L. Milne, Melissa C. Southey

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise